PMID- 29285897 OWN - NLM STAT- MEDLINE DCOM- 20181025 LR - 20210109 IS - 2055-5822 (Electronic) IS - 2055-5822 (Linking) VI - 5 IP - 1 DP - 2018 Feb TI - Impact of a 'stent for life' initiative on post-ST elevation myocardial infarction heart failure: a 15 year heart failure clinic experience. PG - 101-105 LID - 10.1002/ehf2.12245 [doi] AB - AIMS: Multidisciplinary heart failure (HF) clinics are a cornerstone of contemporary HF management. The stent-for-life (SFL) initiative improves mortality after ST elevation myocardial infarction (STEMI), but its impact in post-STEMI HF is not well characterized. Here we assessed the impact of SFL among patients referred to a multidisciplinary HF clinic over a 15 year time period. METHODS AND RESULTS: Between 2001 and 2015, 1921 patients were admitted to our HF clinic. In 2009, Catalonia established the Codi IAM network, a regional STEMI network that prioritizes primary percutaneous coronary intervention in STEMI. Patients admitted during the study period were divided into two groups based on admission date: pre-SFL (2001-June 2009; n = 1031) and post-SFL (July 2009-2015; n = 890). Compared with those in the pre-SFL group, patients admitted in the post-SFL period had better New York Heart Association (NYHA) functional class (22.1 vs. 38.7 NYHA classes III-IV; P < 0.001) and higher left ventricular ejection fraction (LVEF) (36.1 +/- 19.6 vs. 32.6 +/- 13.4; P < 0.001). Among STEMI survivors, 101 (6.7%) pre-SFL patients and 40 (2%) post-SFL patients (P < 0.001) fulfilled the criteria for HF clinic referral (Killip-Kimball class >/= 2 during index admission and/or LVEF of <40%). Furthermore, among patients admitted to the HF clinic, post-STEMI HF with reduced ejection fraction patients comprised 8.9% of the pre-SFL group and only 4.2% of the post-SFL group (P < 0.001). CONCLUSIONS: Among patients treated at our multidisciplinary HF clinic, the adoption of an SFL network has decreased the prevalence of post-STEMI HF with reduced ejection fraction. CI - (c) 2017 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. FAU - Bayes-Genis, Antoni AU - Bayes-Genis A AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. AD - Department de Medicina, Universitat Autonoma de Medicina, Barcelona, Spain. AD - CIBERCV (CB16/11/00403), Instituto de Salud Carlos III, Madrid, Spain. FAU - Garcia, Cosme AU - Garcia C AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. AD - Department de Medicina, Universitat Autonoma de Medicina, Barcelona, Spain. AD - CIBERCV (CB16/11/00403), Instituto de Salud Carlos III, Madrid, Spain. FAU - de Antonio, Marta AU - de Antonio M AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. AD - CIBERCV (CB16/11/00403), Instituto de Salud Carlos III, Madrid, Spain. FAU - Fernandez-Nofrerias, Eduard AU - Fernandez-Nofrerias E AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Domingo, Mar AU - Domingo M AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Zamora, Elisabet AU - Zamora E AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. AD - Department de Medicina, Universitat Autonoma de Medicina, Barcelona, Spain. AD - CIBERCV (CB16/11/00403), Instituto de Salud Carlos III, Madrid, Spain. FAU - Moliner, Pedro AU - Moliner P AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Lupon, Josep AU - Lupon J AD - Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. AD - Department de Medicina, Universitat Autonoma de Medicina, Barcelona, Spain. AD - CIBERCV (CB16/11/00403), Instituto de Salud Carlos III, Madrid, Spain. LA - eng PT - Journal Article DEP - 20171229 PL - England TA - ESC Heart Fail JT - ESC heart failure JID - 101669191 SB - IM MH - Aged MH - *Electrocardiography MH - Female MH - Follow-Up Studies MH - *Forecasting MH - Heart Failure/*etiology/mortality/physiopathology MH - Humans MH - Male MH - Percutaneous Coronary Intervention/*methods MH - Prognosis MH - ST Elevation Myocardial Infarction/complications/diagnosis/*surgery MH - Spain/epidemiology MH - *Stents MH - Stroke Volume/physiology MH - Survival Rate/trends MH - Ventricular Function, Left/*physiology PMC - PMC5793981 OTO - NOTNLM OT - HF with reduced ejection fraction OT - Heart failure clinics OT - Left ventricular ejection fraction OT - New York Heart Association OT - ST elevation myocardial infarction OT - Stent for life COIS- None declared. EDAT- 2017/12/30 06:00 MHDA- 2018/10/26 06:00 PMCR- 2017/12/29 CRDT- 2017/12/30 06:00 PHST- 2017/06/06 00:00 [received] PHST- 2017/10/05 00:00 [revised] PHST- 2017/11/14 00:00 [accepted] PHST- 2017/12/30 06:00 [pubmed] PHST- 2018/10/26 06:00 [medline] PHST- 2017/12/30 06:00 [entrez] PHST- 2017/12/29 00:00 [pmc-release] AID - EHF212245 [pii] AID - 10.1002/ehf2.12245 [doi] PST - ppublish SO - ESC Heart Fail. 2018 Feb;5(1):101-105. doi: 10.1002/ehf2.12245. Epub 2017 Dec 29.